NetworkNewsBreaks

TuesdayDec 17, 2024 2:57 pm

NetworkNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Closes $3.6M Registered Direct

Flora (NASDAQ: FLGC) has closed a registered direct offering to institutional investors for the aggregate purchase and sale of approximately $3.6 million of Common Shares, each at a price of $1.25. Flora announced approximately $3.6 million in expected aggregate gross proceeds from the offering, of which it intends to use the net, together with existing cash, for general corporate purposes and working capital. Aegis Capital Corp. acted as exclusive placement agent for the offering. Dorsey & Whitney LLP acted as counsel to the company, and Kaufman & Canoles P.C. acted as counsel to Aegis Capital Corp. To view the full…

Continue Reading

TuesdayDec 17, 2024 1:48 pm

NetworkNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Delivering End-to-End Solution for EM Programs

SuperCom (NASDAQ: SPCB) is an electronic monitoring (“EM”) innovator bringing advanced technology and monitoring services to government clients for increased use in supervised-release programs. The company’s president and CEO, Ordan Trabelsi, outlined SuperCom’s services and critical benefits during a recent investor presentation at the annual LD Micro Invitational. During the event, Trabelsi explained the competitive edge of the company’s GPS-enabled PureSecurity platform, among a narrow field of rivals. “SuperCom’s end-to-end solution provides a developed GPS technology for reliable offender tracking and 24/7 monitoring services to give criminal justice clients the confidence they need to operate supervised-release programs that allow select individuals…

Continue Reading

TuesdayDec 17, 2024 1:15 pm

NetworkNewsBreaks – Insights from Morgan McGarvey’s Trade in Trump Media & Technology Group Corp. (NASDAQ: DJT) Stock

Democratic Representative Morgan McGarvey recently made headlines with a trade involving Trump Media & Technology Group (NASDAQ: DJT), a company linked to President-elect Donald Trump. The trade occurred on Nov. 6, 2024, just after the presidential election, and was valued between $1,001 and $15,000. This timing was notable as it coincided with provisional results indicating Trump’s re-election. McGarvey, known for opposing Trump’s policies, claimed the purchase was made without his or his spouse’s knowledge and sold the stock two days later at a 7% loss. DJT stock, currently priced at approximately $37.90, has seen a decrease of about 1.57%, with…

Continue Reading

TuesdayDec 17, 2024 11:48 am

NetworkNewsBreaks – Aegis Capital Corp. Acts Sole Bookrunner on $8.4M Underwritten Public Offering for Sacks Parente Golf Inc. (NASDAQ: SPGC)

Aegis Capital has been in the wealth management and investment banking business since 1984 and is dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. Aegis announced that it acted as the sole book-running manager on a $8.4 million underwritten public offering for Sacks Parente Golf (NASDAQ: SPGC). To view the full press release, visit https://nnw.fm/wDYh7 About Sacks Parente Golf Inc. Sacks Parente Golf, a technology-forward golf company, manufactures and sells golf products. The company provides putting instruments, golf shafts, golf grips, and other golf-related products. It also offers…

Continue Reading

TuesdayDec 17, 2024 10:55 am

NetworkNewsBreaks – The Coretec Group Inc. (CRTG) Gains Spotlight on NetworkNewsAudio Following Transformative Acquisition

The Coretec Group (OTCQB: CRTG)  has been prominently featured in a NetworkNewsAudio (“NNA”) broadcast, which highlights the company’s acquisition of a controlling stake in KIB Plug Energy Co., Ltd., a KOSPI-listed South Korean enterprise. NNA, a leading platform for delivering visibility and brand awareness to the investment community, underscores the significance of this acquisition as Coretec advances its position in the global energy and technology sectors. KIB Plug Energy, with operations in 53 countries and annual revenues exceeding $70 million for the past five years, brings substantial expertise in chemical and petroleum plant services. Coretec Co-Chairman Dr. Kim described the…

Continue Reading

TuesdayDec 17, 2024 10:32 am

NetworkNewsBreaks – NextPlat Corp (NASDAQ: NXPL) Launches $2 Million Share Repurchase Program Amid Record Revenue Growth

NextPlat (NASDAQ: NXPL, NXPLW) announced its Board of Directors has approved a share repurchase program of up to $2 million in outstanding common stock. The timing and execution of repurchases will be at the Company's discretion, with flexibility to utilize open market or privately negotiated transactions. NextPlat expects to achieve record 2024 annual revenue exceeding $63 million, a 70% increase over 2023, driven by growth in satellite connectivity products, recurring airtime revenue, and healthcare contributions. CEO Charles M. Fernandez emphasized the company’s focus on double-digit revenue growth and positive operating cashflows in 2025, supported by a strong balance sheet, as…

Continue Reading

TuesdayDec 17, 2024 9:30 am

NetworkNewsBreaks – zSpace Inc. (NASDAQ: ZSPC) Secures $10.8M in IPO

zSpace (NASDAQ: ZSPC) recently closed on its firm commitment initial public offering of an aggregate of 2,156,250 shares of its Common Stock, each at a price of $5.00, including the full exercise of the overallotment option. ZSPC secured gross proceeds of approximately $10.8 million. The shares began trading on the Nasdaq Global Market under the ticker symbol ZSPC on Dec. 5, 2024. Roth Capital Partners acted as joint book-running manager for the offering. To view the full press release, visit https://nnw.fm/Fls4p About zSpace Inc. zSpace delivers innovative augmented and virtual reality (“AR/VR”) experiences for STEM, CTE, and career readiness programs.…

Continue Reading

MondayDec 16, 2024 3:14 pm

NetworkNewsBreaks – Analyst Upgrades and Strategic Focus Drive Optimism for PayPal Holdings Inc. (NASDAQ: PYPL)

PayPal (NASDAQ: PYPL) has recently garnered attention following analyst upgrades and strategic initiatives aimed at revitalizing growth. Wolfe Research upgraded PayPal to “Outperform” with a $107 price target, citing the company’s streamlined focus, expense management and shareholder returns as key factors contributing to a positive outlook. Analysts anticipate growth in areas such as branded checkout innovations, Braintree and Venmo monetization, alongside increased debit card adoption through the PayPal Everywhere rewards campaign. Similarly, Bank of America Securities upgraded PayPal to “Buy” from “Neutral,” raising the price target to $103. This optimism is attributed to PayPal’s turnaround efforts under CEO Alex Chriss,…

Continue Reading

MondayDec 16, 2024 3:03 pm

NetworkNewsBreaks – Torr Metals Inc. (TSX.V: TMET) Leveraging Innovation to Advance High-Potential Targets

Torr Metals Inc. (TSX.V: TMET) is distinguishing itself in Canada’s mining sector, presenting a compelling case for exploration-focused investors. “Torr Metals has consistently demonstrated its ability to identify and advance high-potential exploration targets through innovation and a systematic approach. At Filion, the application of LiDAR technology and targeted surface sampling has uncovered new high-grade zones, establishing a foundation for inaugural drilling on undrilled gold soil anomalies grading up to 1.32 g/t Au in 2023. At Kolos, the discovery of the Sonic Zone represents a significant step forward, identifying another potential large-scale Cu-Au porphyry system alongside previously established targets,” reads a recent…

Continue Reading

MondayDec 16, 2024 1:25 pm

NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Eyes Clear Path Forward for Buntanetap

Annovis Bio (NYSE: ANVS) is a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases, such as Alzheimer’s (“AD”) and Parkinson’s (“PD”). The company concluded the third quarter with the completion of significant milestones and a clear path forward for its lead candidate, buntanetap. “Buntanetap is an innovative drug designed to target neurodegeneration by inhibiting the formation of multiple neurotoxic proteins, including amyloid beta, tau, alpha-synuclein and TDP43,” reads a recent article. “This multifaceted inhibition improves synaptic transmission and axonal transport, reduces neuroinflammation, and protects nerve cells from dying, positioning buntanetap as a potential breakthrough in treating neurodegenerative diseases.”…

Continue Reading